Literature DB >> 8404674

Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy.

R L Sorenson1, T C Brelje, C Roth.   

Abstract

Adaptive changes that occur in islets of Langerhans during pregnancy include enhanced insulin secretion, insulin synthesis, beta-cell proliferation, gap-junctional coupling among beta-cells, and glucose oxidation. We have determined that elevated lactogenic activity is directly responsible for these changes in beta-cell function. Recently, we showed that two of the principal adaptive characteristics (insulin secretion and beta-cell proliferation) of rat pregnancy peaked on day 15 and returned to control levels by day 20. As placental lactogen remains elevated during late gestation, it was of interest to determine whether pregnancy steroids could reverse the effects of lactogen on islets. In this study, rat islets were cultured with progesterone, estradiol, rat PRL (rPRL), or combinations of these hormones (progesterone and rPRL, estradiol and rPRL, or progesterone and estradiol and rPRL). Insulin secretion was examined for 8 days, and beta-cell proliferation by 2-bromo-5'-deoxyuridine (BrdU) incorporation on days 4 and 8. rPRL treatment resulted in a time-dependent increase in insulin secretion that was 3-fold greater than that from control islets by day 8. Progesterone and estradiol had minimal effects on insulin secretion. Estradiol had no effect on the increased insulin secretion observed with rPRL during the first 6 days and a small inhibitory effect on days 7 and 8. Although progesterone treatment had no effect on the increased insulin secretion induced by rPRL during the first 3 days, it subsequently resulted in a decline in insulin secretion to that from control islets. The combination of progesterone and estradiol was more effective than either steroid by itself in reversing the effects of rPRL on insulin secretion. Similar results were obtained in the BrdU labeling experiments: 1) a 7-fold increase in the number of BrdU-labeled nuclei per islet was observed after culture in the presence of rPRL; and 2) estradiol had a small inhibitory effect on the increased BrdU labeling observed with rPRL; however, 3) progesterone completely reversed the effect of rPRL on islet beta-cell division. These results demonstrate that progesterone counterregulates the effects of PRL on insulin secretion and islet beta-cell division. The temporal changes observed in islets in vitro under the influence of PRL and progesterone mimic those seen in islets during pregnancy. We conclude that progesterone, which increases in the later stages of gestation, is the primary hormone responsible for counteracting the stimulatory effects of elevated lactogenic activity on islets during late pregnancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404674     DOI: 10.1210/endo.133.5.8404674

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  32 in total

1.  Is there an estrogenic component in the metabolic syndrome?

Authors:  S Starcke; G Vollmer
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

2.  Role of 17-beta-estradiol and progesterone on glucose homeostasis: effects of food restriction (50%) in pregnant and non pregnant rats.

Authors:  C G González; F D García; S F Fernández; A M Patterson
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

3.  MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.

Authors:  Cécile Jacovetti; Amar Abderrahmani; Géraldine Parnaud; Jean-Christophe Jonas; Marie-Line Peyot; Marion Cornu; Ross Laybutt; Emmanuelle Meugnier; Sophie Rome; Bernard Thorens; Marc Prentki; Domenico Bosco; Romano Regazzi
Journal:  J Clin Invest       Date:  2012-09-10       Impact factor: 14.808

4.  Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation.

Authors:  Frédéric Picard; Mitsuhiro Wanatabe; Kristina Schoonjans; John Lydon; Bert W O'Malley; Johan Auwerx
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-15       Impact factor: 11.205

Review 5.  Role of Sex Steroids in β Cell Function, Growth, and Survival.

Authors:  Franck Mauvais-Jarvis
Journal:  Trends Endocrinol Metab       Date:  2016-09-15       Impact factor: 12.015

Review 6.  Minireview: Estrogenic protection of beta-cell failure in metabolic diseases.

Authors:  Suhuan Liu; Franck Mauvais-Jarvis
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

Review 7.  Replicative capacity of β-cells and type 1 diabetes.

Authors:  Diane Saunders; Alvin C Powers
Journal:  J Autoimmun       Date:  2016-04-28       Impact factor: 7.094

8.  Pancreatic expression and mitochondrial localization of the progestin-adipoQ receptor PAQR10.

Authors:  L Jorge Góñez; Gaetano Naselli; Ilia Banakh; Hideo Niwa; Leonard C Harrison
Journal:  Mol Med       Date:  2008-08-20       Impact factor: 6.354

Review 9.  β-Cell adaptation in pregnancy.

Authors:  L Baeyens; S Hindi; R L Sorenson; M S German
Journal:  Diabetes Obes Metab       Date:  2016-09       Impact factor: 6.577

10.  The interplay of prolactin and the glucocorticoids in the regulation of beta-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: implications for carbohydrate metabolism in pregnancy.

Authors:  Ramamani Arumugam; Eric Horowitz; Danhong Lu; J Jason Collier; Sarah Ronnebaum; Don Fleenor; Michael Freemark
Journal:  Endocrinology       Date:  2008-07-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.